全文获取类型
收费全文 | 167517篇 |
免费 | 15584篇 |
国内免费 | 7796篇 |
专业分类
耳鼻咽喉 | 2286篇 |
儿科学 | 3809篇 |
妇产科学 | 1819篇 |
基础医学 | 30747篇 |
口腔科学 | 5354篇 |
临床医学 | 12895篇 |
内科学 | 22753篇 |
皮肤病学 | 4433篇 |
神经病学 | 9483篇 |
特种医学 | 3683篇 |
外国民族医学 | 118篇 |
外科学 | 14548篇 |
综合类 | 25669篇 |
现状与发展 | 48篇 |
预防医学 | 4656篇 |
眼科学 | 3500篇 |
药学 | 12837篇 |
30篇 | |
中国医学 | 5038篇 |
肿瘤学 | 27191篇 |
出版年
2024年 | 355篇 |
2023年 | 2431篇 |
2022年 | 4259篇 |
2021年 | 6048篇 |
2020年 | 5372篇 |
2019年 | 5196篇 |
2018年 | 5384篇 |
2017年 | 5688篇 |
2016年 | 5962篇 |
2015年 | 6809篇 |
2014年 | 9839篇 |
2013年 | 10889篇 |
2012年 | 9432篇 |
2011年 | 10600篇 |
2010年 | 8801篇 |
2009年 | 8444篇 |
2008年 | 8888篇 |
2007年 | 9101篇 |
2006年 | 8264篇 |
2005年 | 7590篇 |
2004年 | 6745篇 |
2003年 | 5832篇 |
2002年 | 4803篇 |
2001年 | 4112篇 |
2000年 | 3399篇 |
1999年 | 3065篇 |
1998年 | 2904篇 |
1997年 | 2654篇 |
1996年 | 2379篇 |
1995年 | 2072篇 |
1994年 | 1830篇 |
1993年 | 1525篇 |
1992年 | 1236篇 |
1991年 | 1167篇 |
1990年 | 897篇 |
1989年 | 845篇 |
1988年 | 793篇 |
1987年 | 631篇 |
1986年 | 588篇 |
1985年 | 777篇 |
1984年 | 694篇 |
1983年 | 489篇 |
1982年 | 509篇 |
1981年 | 407篇 |
1980年 | 341篇 |
1979年 | 256篇 |
1978年 | 179篇 |
1977年 | 139篇 |
1976年 | 103篇 |
1975年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
102.
《Vaccine》2020,38(10):2315-2325
In the preparation of glycoconjugate vaccines in clinical practice, two highly immunogenic carrier proteins, CRM197 and tetanus toxoid (TT), are predominantly conjugated with the capsular polysaccharides (CPSs) of bacterial pathogens. In addition, TT has long been used as an effective vaccine to prevent tetanus. While these carrier proteins play an important role in immunogenicity and vaccine design alike, their defined human major histocompatibility complex class II (MHCII) T cell epitopes are inadequately characterized. In this current work, we use mass spectrometry to identify the peptides from these carrier proteins that are naturally processed and presented by human B cells via MHCII pathway. The MHCII-presented peptides are screened for their T cell stimulation using primary CD4+ T cells from four healthy adult donors. These combined methods reveal a subset of eleven CD4+ T cell epitopes that proliferate and stimulate human T cells with diverse MHCII allelic repertoire. Six of these peptides stand out as potential immunodominant epitopes by responding in three or more donors. Additionally, we provide evidence of these natural epitopes eliciting more significant T cell responses in donors than previously published TT peptides selected from T cell epitope screening. This study serves toward understanding carrier protein immune responses and thus enables the use of these peptides in developing novel knowledge-based vaccines to combat persisting problems in glycoconjugate vaccine design. 相似文献
103.
104.
Sickle cell disease (SCD) is a highly complex inherited disorder of hemoglobin structure. Although the molecular lesion is a single-point mutation, the sickle gene is pleiotropic in nature causing multiple phenotypic expressions that constitute the various complications of the disease. Its manifestations could be acute, chronic, nociceptive, neuropathic that could occur singly or in various combinations. Pain continues to be the major factor of SCD phenotypic complications and the most common cause of admissions to the Emergency Department and/or the hospital. Although progress has been made in understanding the pathophysiology of SCD as well as in developing curative therapies such as hematopoietic stem cell transplantation and gene therapy, effective pain management continues to lag behind. Palliative therapies continue to be the major approach to the management of SCD and its complications. The advent of hydroxyurea made partial success in preventing the frequency of vaso-occlusive crises and l-glutamine awaits post-trial confirmation of benefits. The search for additional pharmacotherapeutic agents that could be used singly or in combination with hydroxyurea and/or l-glutamine awaits their dawn hopefully in the near future. The purpose of this review is to describe the various manifestations of SCD, their pathophysiology and their current management. Recent impressive advances in understanding the pathophysiology of pain promise the determination of agents that could replace or minimize the use of opioids. 相似文献
105.
106.
107.
目的:探讨a-1,2岩藻糖基转移酶II(FUT2)在肺鳞癌中的表达情况及其对肺鳞癌细胞增殖的影响。方法:应用UALCAN数据库分析FUT2在临床肺鳞癌患者组织中的差异表达及其与肺鳞癌患者临床TNM分期、年龄及性别因素的相关性;采用瞬时转染技术,将FUT2的shRNA质粒转染进H226细胞株中构建FUT2低表达的肺鳞癌细胞模型;利用CCK-8、平板克隆及Western blot实验检测FUT2对肺鳞癌细胞的生长、单克隆细胞团形成及PCNA蛋白表达的影响。结果:FUT2在肺鳞癌尤其是肺鳞癌TNM早中期呈现高表达趋势(P<0.05),而与年龄和性别无关。低表达FUT2可以抑制肺鳞癌细胞的生长速率和单克隆细胞团的形成数,同时,可以抑制肺鳞癌细胞PCNA蛋白的表达水平,差异均有统计学意义(P<0.05)。结论:FUT2在肺鳞癌中高表达且促进肺鳞癌细胞的增殖能力,有望成为肺鳞癌的早期诊断指标。 相似文献
108.
ObjectiveProgrammed death ligand 1 (PD-L1) has been reported to be connected to prognosis in individuals with malignant pleural mesothelioma (MPM), although there is no consensus based on data from previous studies. Accordingly, this quantitative meta-analysis investigated prognostic and clinicopathological utility of PD-L1 in patients with MPM.MethodsA comprehensive search of the PubMed, Web of Science, Embase, and Cochrane Library databases for articles published up to October 4, 2019 was performed. Studies using immunohistochemical techniques to detect/quantify the expression of PD-L1 in MPM tissue were enrolled in the analysis. The combined hazard ratio (HR) and corresponding 95% confidence interval (CI) was applied to assess the association between PD-L1 expression and overall survival (OS).ResultsA total of 11 studies comprising 1606 patients was included in the present meta-analysis. For OS, pooled data revealed an HR of 1.50 (95% CI 1.32–1.70; p < 0.001), suggesting that patients with PD-L1 overexpression experience inferior OS. Subgroup analysis revealed that elevated PD-L1 remained a significant prognostic indicator for worse OS, irrespective of sample size, cut-off value, ethnicity, and Newcastle-Ottawa Scale score. Moreover, PD-L1 overexpression was associated with non-epithelioid histology (odds ratio 4.30 [95% CI 1.89–9.74]; p < 0.001).ConclusionsResults of this meta-analysis show that elevated expression of PD-L1 could be a factor predicting poorer survival in patients with MPM. 相似文献
109.
110.